4Lee AU, Farrell GC. Mechanism of azathioprine-induced injury tohepatocytes roles of glutathione depletion and mitochondrial injury [J]. J Hepatol, 2001, 35(6):756- 764.
5Weinshilboum R. Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyhransferase [J]. Drug Metab Dispos, 2001, 29 (4 Pt 2) :601-605.
6Weinshilboum R.Thiopurine pharmacogenetics:clinical and molecular studies of thiopurine methyltransferase.Drug Metab Dispos 2001;29(4 pt 2):601-605.
7Schaeffeler E,Fischer C,Brockmeier D,et al.Comprehensive analysis of thiopurine S-methyltransferase phenotype genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants.Pharmacogenetics 2004;14(7):407-417.
8McLeod HL,Siva C.The thiopurine S-methyltransferase gene locus implications for clinical pharmacogenomics.Pharmacogenomics 2002;3(1):89-98.
9Zhang JP,Zhou SF,Chen X,et al.Determination of in tra-ethnic difference in the polymorphisms of thiopurine S methyltransferase in Chinese.Clin Chim Acta 2006;365(1/2):337-341.
10Krynetski EY,Evans WE.Genetic polymorphism of thiopurine S-methyltransferase:molecular mechanisms and clinical importance.Pharmacology 2000;61(3):136-146.
